Ragnhild Johanne Måseide

  • Consultant; MD, PhD
  • +47 23 07 36 54
 

Publications 2023

Hillarp A, Holme PA, Wåland EP, Le MS, Henriksson CE, Tjønnfjord GE, Måseide RJ (2023)
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
J Thromb Haemost, 21 (10), 2771-2775
DOI 10.1016/j.jtha.2023.07.019, PubMed 37543216

Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2023)
Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
Haemophilia, 30 (1), 98-105
DOI 10.1111/hae.14899, PubMed 37983883

Publications 2021

Måseide RJ, Berntorp E, Astermark J, Hansen J, Olsson A, Bruzelius M, Frisk T, Aspdahl M, Nummi V, Tjønnfjord GE, Holme PA (2021)
Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study
Haemophilia, 27 (2), e253-e259
DOI 10.1111/hae.14245, PubMed 33550602

Måseide RJ, Berntorp E, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2021)
Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation
Haemophilia, 27 (5), 793-801
DOI 10.1111/hae.14355, PubMed 34106506

Publications 2020

Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2020)
Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B - The MoHem study
Haemophilia, 26 (5), 891-897
DOI 10.1111/hae.14114, PubMed 33021747

Page visits: 5472